This article explores the critical and ongoing validation of the Belmont Report's ethical principles—Respect for Persons, Beneficence, and Justice—within the complex landscape of contemporary gene and cell therapy trials.
This article examines the profound and lasting impact of the Belmont Report on the landscape of biomedical and clinical research.
This article provides a comprehensive analysis of the relationship between principlism—the dominant framework of the four principles (autonomy, beneficence, non-maleficence, and justice)—and the concept of a universal common morality in...
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on applying the ethical principles of the Belmont Report within the distinct regulatory frameworks of the FDA...
This article provides a comprehensive comparison of the Belmont Report's ethical principles and the Common Rule's regulatory requirements, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive framework for researchers and drug development professionals to critically evaluate their Institutional Review Board (IRB) protocols for genuine adherence to the Belmont Report's ethical principles.
This article provides a comprehensive analysis of the effectiveness of the Belmont Report in safeguarding human subjects in biomedical and clinical research.
This article provides a detailed comparative analysis of the Belmont Report and the CIOMS International Ethical Guidelines, two cornerstone frameworks for ethical human subjects research.
This article provides a comprehensive framework for researchers and drug development professionals on modifying clinical trial protocols for subjects with cognitive impairment.
This article provides a structured ethical decision-making framework for Institutional Review Board (IRB) members, researchers, and drug development professionals.